MEDILINK
LIVE

Serial Number

97230276

Owner

MediLink Therapeutics(Suzhou)Co.,Ltd.

Attorney

Timothy T. Wang

First Use Date

Jun 30, 2020

Filing Date

Jan 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MEDILINK Trademark

Serial Number: 97230276 • Registration: 7388604

MEDILINK is a trademark filed by MediLink Therapeutics(Suzhou)Co.,Ltd. on January 20, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MediLink Therapeutics(Suzhou)Co.,Ltd. (12 trademarks)

101 N. BLK B3, Biology Industrial Park
Suzhou, Jiangsu 215000 , CN

Entity Type: 99

Trademark Details

Filing Date

January 20, 2022

Registration Date

May 14, 2024

First Use Anywhere

June 30, 2020

First Use in Commerce

June 30, 2020

Published for Opposition

June 13, 2023

Goods & Services

Biochemical research and development; Biomedical research services; Biotechnology research; Chemical research; Chemical research and analysis; Chemistry consultation; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Professional consulting services and advice about agricultural chemistry; Research and development in the field of antibody-drug conjugates; Research and development in the field of antibody conjugates; Research and development in the field of drug conjugates; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research in the field of chemistry; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the nature of conducting clinical trials for others; Technology research in the field of pharmaceutical preparations and medical instruments; Testing of chemicals; Testing of cosmetics; Testing of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 14, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 14, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 12, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 11, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2024 CRFA
ASSIGNED TO LIE
Mar 19, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 20, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 20, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 28, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 28, 2023 AITU
USE AMENDMENT FILED
Aug 22, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 22, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 8, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 13, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 13, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2022 NWOS
NEW APPLICATION ENTERED
Jan 24, 2022 NWAP